Chrystalleni Hadjicharalambous

Chrystalleni Hadjicharalambous

Auto-generated profile, based on publicly available information

Chrystalleni Hadjicharalambous

Department of Chemistry, University of Crete, Heraklion 70013, Greece; Medicina Veterinaria, Laboratorio di Ispezione degli Alimenti di Origine Animale, Universita degli Studi di Perugia, 06126 Perugia, Italy; European Food Safety Authority, EU-FORA Programme, Parma, 43126, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2020 in Chemical Communications
Verified
Journal Article
Open access
PDF file
MVMaria Vassaki
Maria Vassaki
KPKonstantinos Papathanasiou
Konstantinos Papathanasiou
CHChrystalleni Hadjicharalambous
Chrystalleni Hadjicharalambous
DCDaphne Chandrinou
Daphne Chandrinou
Petri TurhanenPetri Turhanen
Petri Turhanen
KDKonstantinos D. Demadis
Konstantinos D. Demadis
In this paper we report drug delivery systems that are based on phosphonate MOFs. These employ biologically-acceptable metal ions (e.g. Ca2+ and Mg2+) and several anti-osteoporosis bisphosphonate drugs (etidronate, pamidronate, alendronate and neridronate), as the organic linkers. These materials have been synthesized, structurally characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the bisphosphonate active ingredient. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Their cytotoxicity profiles match those of the active ingredients.

30 July 2022 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
CHChrystalleni Hadjicharalambous
Chrystalleni Hadjicharalambous
LGLuca Grispoldi
Luca Grispoldi
TCThanos Chalias
Thanos Chalias
BCBeniamino Cenci-Goga
Beniamino Cenci-Goga